Table 1 Characteristics of patients with androgen-sensitive, oligometastatic prostate cancer (Oli-P study cohort) that received ablative radiotherapy with curative intend to metastatic lesions. Patients were treated at the Department of Radiotherapy and Radiation Oncology of the University Hospital Carl Gustav Carus, Dresden (ClinicalTrials.gov Identifier: NCT02264379) between 2014 and 2021
Parameter | Number of patients | % |
|---|---|---|
ISUP grade | ||
High (≥ 4) | 10/31 | 32% |
NCCN risk group | ||
Low | 0/31 | 0% |
Intermediate | 9/31 | 29% |
High, very high, local advanced | 22/31 | 71% |
Metastases | ||
Lymph node | 21/31 | 68% |
Bone | 6/31 | 19% |
Both | 4/31 | 13% |
Radiotherapy to metastases | ||
Normo-fractionation (25 × 2 Gy) | 7/31 | 23% |
Hypo-fractionation (3 × 10 Gy) | 24/31 | 77% |
Parameter | Mean | Range |
Age (years) | 73 | 53–84 |
Gross tumor volume (GTV) (ccm) | 3.0 | 0.1–11.0 |
PSA before radiotherapy (ng/ml) | 3.02 | 0.69–8.78 |